Discovery lays foundation for gene therapy in hereditary deafness
Preclinical study could pave the way for gene therapy to restore hearing in children born deaf with Usher syndrome
Preclinical study could pave the way for gene therapy to restore hearing in children born deaf with Usher syndrome
Her research aims to better understand the root causes of dyslexia and spur neural plasticity, or the brain’s ability to adapt, using noninvasive vagus nerve stimulation to improve reading and language skills.
A new study led by MBI researchers has found that using certain FDA-approved medications for addiction treatment was not associated with worse outcomes or additional impairment among participants in Florida’s physician health program.
In The Conversation, Dr. Ramon Sun discusses his study reporting an increased mortality risk among Alzheimer's patients using Glucosamine.
Dr. Kimberly Alonge's research explores the role of the brain’s extracellular matrices in neuro disorders as well as in aging, obesity and diabetes.
Research team seeks to improve clinicians’ ability to distinguish between diseases involving dementia.
In the Washington Post, Dr. Zak Krumm discusses studies into how GLP-1 drugs may affect dopamine signaling and brain reward processing.
MBI researcher Dr. Lisa Merlo led a study finding that 95% of health care professionals who completed a PHP said their experience met or exceeded expectations.
Longtime faculty member, medical director of Florida Recovery Center, passed away April 16.
MBI awards provide seed funding to bolster emerging research in neuroscience and neuromedicine across the University of Florida.